Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Francesc Viñals

Showing results (51-60 of 58) with videos related to

Pageof 6
Sort By:
You have reached the last page of results.This site can display upto 58 results.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|August 17, 2012
Lurbinectedin (PM01183), a new DNA minor groove binder, inhibits growth of orthotopic primary graft of cisplatin-resistant epithelial ovarian cancerAugust Vidal, Clara Muñoz, María-José Guillén, et al.
Advanced Science (Weinheim, Baden-Wurttemberg, Germany)|November 14, 2022
Generation and Integrated Analysis of Advanced Patient-Derived Orthoxenograft Models (PDOX) for the Rational Assessment of Targeted Therapies in Endometrial CancerLaura Devis-Jauregui, August Vidal, Laura Plata-Peña, et al.
Nature Metabolism|January 30, 2026
Glucose deprivation drives LIF-dependent lung cancerFedra Luciano-Mateo, Joaquim Moreno-Caceres, Miguel Hernández-Madrigal, et al.
Nature Communications|April 5, 2014
A DERL3-associated defect in the degradation of SLC2A1 mediates the Warburg effectPaula Lopez-Serra, Miguel Marcilla, Alberto Villanueva, et al.
EMBO Molecular Medicine|June 19, 2013
CDK-mediated activation of the SCF(FBXO) (28) ubiquitin ligase promotes MYC-driven transcription and tumourigenesis and predicts poor survival in breast cancerDiana Cepeda, Hwee-Fang Ng, Hamid Reza Sharifi, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|April 6, 2018
Orthoxenografts of Testicular Germ Cell Tumors Demonstrate Genomic Changes Associated with Cisplatin Resistance and Identify PDMP as a Resensitizing AgentJosep M Piulats, August Vidal, Francisco J García-Rodríguez, et al.
NAR Cancer|March 10, 2025
Harnessing transcriptional regulation of alternative end-joining to predict cancer treatmentRoderic Espín, Ferran Medina-Jover, Javier Sigüenza-Andrade, et al.
EMBO Molecular Medicine|August 11, 2021
Histamine signaling and metabolism identify potential biomarkers and therapies for lymphangioleiomyomatosisCarmen Herranz, Francesca Mateo, Alexandra Baiges, et al.
Pageof 6

Showing results (51-60 of 58) with videos related to

Sort By:
Pageof 6
You have reached the last page of results.This site can display upto 58 results.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|August 17, 2012
Lurbinectedin (PM01183), a new DNA minor groove binder, inhibits growth of orthotopic primary graft of cisplatin-resistant epithelial ovarian cancerAugust Vidal, Clara Muñoz, María-José Guillén, et al.
Advanced Science (Weinheim, Baden-Wurttemberg, Germany)|November 14, 2022
Generation and Integrated Analysis of Advanced Patient-Derived Orthoxenograft Models (PDOX) for the Rational Assessment of Targeted Therapies in Endometrial CancerLaura Devis-Jauregui, August Vidal, Laura Plata-Peña, et al.
Nature Metabolism|January 30, 2026
Glucose deprivation drives LIF-dependent lung cancerFedra Luciano-Mateo, Joaquim Moreno-Caceres, Miguel Hernández-Madrigal, et al.
Nature Communications|April 5, 2014
A DERL3-associated defect in the degradation of SLC2A1 mediates the Warburg effectPaula Lopez-Serra, Miguel Marcilla, Alberto Villanueva, et al.
EMBO Molecular Medicine|June 19, 2013
CDK-mediated activation of the SCF(FBXO) (28) ubiquitin ligase promotes MYC-driven transcription and tumourigenesis and predicts poor survival in breast cancerDiana Cepeda, Hwee-Fang Ng, Hamid Reza Sharifi, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|April 6, 2018
Orthoxenografts of Testicular Germ Cell Tumors Demonstrate Genomic Changes Associated with Cisplatin Resistance and Identify PDMP as a Resensitizing AgentJosep M Piulats, August Vidal, Francisco J García-Rodríguez, et al.
NAR Cancer|March 10, 2025
Harnessing transcriptional regulation of alternative end-joining to predict cancer treatmentRoderic Espín, Ferran Medina-Jover, Javier Sigüenza-Andrade, et al.
EMBO Molecular Medicine|August 11, 2021
Histamine signaling and metabolism identify potential biomarkers and therapies for lymphangioleiomyomatosisCarmen Herranz, Francesca Mateo, Alexandra Baiges, et al.
Pageof 6